bendamustine hydrochloride and Cancer of Lung
bendamustine hydrochloride has been researched along with Cancer of Lung in 8 studies
Research
Studies (8)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Carbone, DP; Horn, L; Hutchison, AS; Johnson, DH; Keedy, VL; Lammers, PE; Li, CI; Sandler, A; Shyr, Y | 1 |
Dubey, P; Gidwani, B; Pandey, R; Shukla, SS | 1 |
Allendorf, DJ; Bordoni, RE; Dixon, PM; Grant, SC; Jerome, ML; Miley, DK; Reddy, VB; Robert, F; Saleh, MN; Singh, KP | 1 |
Heinrich, G; Loibl, S; Müller, L; Murmann, C; Nekljudova, V; Schwedler, K; von Minckwitz, G; Warm, M | 1 |
Alam, S; Layman, R; Lustberg, M; Reinbolt, RE; Shapiro, C | 1 |
Hortig, P; Keilholz, U; Knödler, M; Schmittel, A; Schulze, K; Thiel, E | 1 |
Fischer, JR; Heider, A; Koch, JA; Köster, W; Niederle, N; Stahl, M; Stamatis, G; Wilke, H | 1 |
Gatzemeier, U; Haering, B; Kaukel, E; Koschel, G; Reck, M; von Pawel, J | 1 |
Trials
6 trial(s) available for bendamustine hydrochloride and Cancer of Lung
Article | Year |
---|---|
Phase II study of bendamustine in relapsed chemotherapy sensitive or resistant small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitrogen Mustard Compounds; Prognosis; Salvage Therapy; Small Cell Lung Carcinoma; Survival Rate | 2014 |
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Biomarkers, Tumor; Brain Diseases, Metabolic; Camptothecin; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Endonucleases; Etoposide; Fatigue; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Mitosis; Multiple Organ Failure; Pneumonia; Treatment Outcome; Weight Loss | 2015 |
Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Paclitaxel; Pleural Neoplasms; Survival Rate; Treatment Outcome | 2009 |
Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients.
Topics: Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Carcinoma, Small Cell; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrogen Mustard Compounds; Recurrence; Survival Analysis; Time Factors | 2007 |
Phase II trial with carboplatin and bendamustine in patients with extensive stage small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Carboplatin; Carcinoma, Non-Small-Cell Lung; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Patient Selection; Probability; Risk Assessment | 2007 |
[Chemotherapy of advanced non-small-cell and small-cell bronchial carcinoma with bendamustine--a phase II study].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bendamustine Hydrochloride; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Palliative Care; Survival Rate; Treatment Outcome | 1998 |
Other Studies
2 other study(ies) available for bendamustine hydrochloride and Cancer of Lung
Article | Year |
---|---|
In vitro and in vivo evaluation of PEGylated nanoparticles of bendamustine for treatment of lung cancer.
Topics: Animals; Bendamustine Hydrochloride; Cell Line, Tumor; Drug Delivery Systems; Humans; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Polyethylene Glycols; Xenograft Model Antitumor Assays | 2016 |
Pneumocystis jiroveci Pneumonia in an Atypical Host.
Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bevacizumab; Breast Neoplasms; CD4 Lymphocyte Count; Clinical Trials, Phase I as Topic; Dexamethasone; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Paclitaxel; Pneumocystis carinii; Pneumonia, Pneumocystis; Quinazolines; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |